Stress urinary incontinence: New management options

Current Medical Research and Opinion

Volumn 21, Issue 10, 2005, Pages 1669-1675

  Jackson, Simon ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Conservative management; Duloxetine; Pharmacological management; Stress urinary incontinence; Surgical management; Urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CIPROFLOXACIN; DULOXETINE; ENOXACIN; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BLADDER SURGERY; BLOOD ANALYSIS; BREAST FEEDING; CLINICAL TRIAL; COHORT ANALYSIS; COLPOSUSPENSION; CONSERVATIVE TREATMENT; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG CONTRAINDICATION; DRUG INDICATION; ELECTROSTIMULATION; EXERCISE; FATIGUE; FINANCIAL MANAGEMENT; FOLLOW UP; HEADACHE; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HUMAN; INSOMNIA; LIVER DISEASE; LONG TERM CARE; MAGNETIC STIMULATION; NAUSEA; NERVE STIMULATION; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREGNANCY; PROSPECTIVE STUDY; PUDENDAL NERVE; QUALITY OF LIFE; RISK ASSESSMENT; SHORT SURVEY; STRESS INCONTINENCE; TENSION FREE VAGINAL TAPE; TREATMENT INDICATION; UNITED KINGDOM; XEROSTOMIA;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; URINARY INCONTINENCE, STRESS;

EID: 27144502727     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X65565     Document Type: Short Survey

References (43)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Urology 2003;61:37-49
2. Hunskaar S, Lose G, Sykes D, et al. The prevalence of urinary incontinence in women in four European countries. BJU Int 2004;93:324-330
3. Hampel C, Wienhold D, Benken N, et al. Definition of overactive bladder and epidemiology of urinary incontinence. Urology 1997;50:4-14
4. O'Brien J, Austin M, Sethi P, et al. Urinary incontinence: prevalence, need for treatment, and effectiveness of intervention by nurse. BMJ 1991;303:1308-12
5. Perry S, Shaw C, Assassa P, et al. and the Leicestershire MRC Incontinence Team. An epidemiological study to establish the prevalence of urinary symptoms and felt need in the community: the Leicestershire MRC Incontinence Study. J Public Health Med 2000;22:427-34
6. Norton PA, MacDonald LD, Sedgwick PM, et al. Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ 1988;297:1187-9
7. Norton C. The effects of urinary incontinence in women. Int Rehab Med 1982;4:9-14
8. Department of Health. Good Practice in Continence Services. London: Department of Health, 2000
9. Continence Foundation. Making the case for investment in an integrated continence service. Available from http://www. continence-foundation.org.uk/in- depth/integrated-continence-service.php [Accessed 1 July 2004], 2000
10. Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. WHI 2003;13:204-13
11. Habib L. Disease care costly for women. Costs skyrocketing for over 65s with certain conditions. Elmwood Park, NJ: WebMDHealth, 2002
12. Doran CM, Chiarelli P, Cockburn J. Economic costs of urinary incontinence in community-dwelling Australian women. MJA 2001;174:456-8
13. Viktrup L. Female stress and urge incontinence in family practice: insight into the lower urinary tract. Int J Clin Pract 2002; 56:694-700
14. DeGroat WC, Downie JW, Levin RM, et al. Basic neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein A, editors. Incontinence. Plymouth: Plymouth Distributors; 1999. pp.105-55
15. 2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacology 1996; 118:150-4
16. Thakar R, Stanton S. Management of urinary incontinence in women. BMJ 2000;321:1326-31
17. Mørkved S, Bø K, Schei B, et al. Pelvic floor muscle training during pregnancy to prevent urinary incontinence: a single-blind randomized controlled trial. Obstet Gynecol 2003;101:313-9
18. Bø K, Talseth T, Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ 1999;318:487-93
19. Sullivan J, Abrams P. Pharmacological management of incontinence. Eur Urol 1999;36(Suppl 1):89-95
20. Lin HH, Sheu BC, Lo MC, et al. Comparison of treatment outcomes of imipramine for female genuine stress incontinence. BJOG 1999; 106:1089-92
21. 1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 1998; 123:1289-93
22. Andersson KE. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 2nd edn. Committee 9, Plymouth: Plymbridge Distributors Ltd 2002. pp.479-511
23. Alhasso A, Glazener CM, Pickard R, et al. Adrenergic drugs for urinary incontinence in adults (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd
24. Jackson S, Shepherd A, Brookes S, et al. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. BJOG 1999; 106: 711-8
25. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd
26. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the cholarose-anesthestized female cat. J Pharmacol Exp Ther 1995;274:1014-24
27. Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003; 170:1259-63
28. van Kerrebroeck P, Abrams P, Lange R, et al. for the Duloxetine Urinary Incontinence Study Group. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004;111:249-57
29. Millard RJ, Moore K, Rencken R, et al. for the Duloxetine UI Study Group. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 2004;93:311-8
30. Electronic Medicines Compendium. Yentreve SPC. Available from http://www.emc.medicines.org.uk [Accessed 5 May 2005]
31. Black N, Griffiths J, Pope C, et al. Impact of surgery for stress incontinence on morbidity: cohort study. BMJ 1997;315:1493-8
32. National Institute for Clinical Excellence. Guidance on the use of tension-free vaginal tape (Gynecare TVT) for stress incontinence. NICE Technology Appraisal guideline - No. 56. London: NICE, 2003
33. Moehrer B, Carey M, Wilson D. Laparoscopic colposuspension: a systemic review. BJOG 2003;110:230-5
34. Ward K, Hilton P, on behalf of the United Kingdom and Ireland Tension-free Vaginal Tape Trial Group. Prospective multicentre randomised trial of the tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 2002;325:1-7
35. Ward K, Hilton P, on behalf of the United Kingdom and Ireland Tension-free Vaginal Tape Trial Group. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: Two-year follow-up. Am J Obstet Gynecol 2004;190:324-31
36. Richter HE, Norman AM, Burgio KL, et al. Tension-free vaginal tape: a prospective subjective and objective outcome analysis. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16:109-13
37. Nilsson CG, Falconer C, Rezapour M. Seven-year follow-up of the tension-free vaginal tape procedure for treatment of urinary incontinence. Obstet Gynecol 2004;104:1259-62
38. de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 2003;44:724-30
39. National Institute for Health and Clinical Excellence. Interventional procedures overview of transobturator tape insertion for stress urinary incontinence. Available from: http://www.nice.org.uk/pdf/ip/ip223overview.pdf [Accessed 5 May 2005]
40. Pickard R, Reaper J, Wyness L, et al. Periurethral injection therapy for urinary incontinence in women (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd
41. Fujishiro T, Enomoto H, Ugawa Y, et al. Magnetic stimulation of the sacral roots for the treatment of stress urinary incontinence: an investigational study and placebo controlled trial. J Urol 2000;16:1277-9
42. National Institute for Health and Clinical Excellence. Urinary incontinence. Available from http://www.nice.org.uk/page. aspx?o=63363 [Accessed 21 July 2005]
43. Scottish Intercollegiate Guidelines Network. (2004) Management of urinary incontinence in primary care. Available from http://www.sign.ac.uk/pdf/sign79. pdf [Accessed 21 July 2005]